{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:56Z","timestamp":1758040136206,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ahj.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T05:57:15Z","timestamp":1584079035000},"page":"264-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Back to the future\u2014Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?"],"prefix":"10.1016","volume":"226","author":[{"given":"Jason N.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2020.03.006_bb0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock","volume":"34","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.03.006_bb0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2020.03.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007270","article-title":"Hospital variation in the utilization of short-term nondurable mechanical circulatory support in myocardial infarction complicated by cardiogenic shock","volume":"12","author":"Strom","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2020.03.006_bb0020","article-title":"Clinical practice patterns in temporary mechanical circulatory support for shock in the Critical Care Cardiology Trials Network (CCCTN) registry","volume":"11","author":"Berg","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2020.03.006_bb0025","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1097\/CCM.0000000000003252","article-title":"Adenosine plasma level and A2A receptor expression in patients with cardiogenic shock","volume":"46","author":"Gaubert","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ahj.2020.03.006_bb0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ejhf.117","article-title":"Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"16","author":"Fuernau","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2020.03.006_bb0035","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2020.03.006_bb0040","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Poss","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.03.006_bb0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2003-45422","article-title":"Initial experiences with the Impella device in patients with cardiogenic shock\u2014Impella support for cardiogenic shock","volume":"51","author":"Meyns","year":"2003","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2020.03.006_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10047-017-0966-5","article-title":"Temporary biventricular support with extracorporeal membrane oxygenation: a feasible therapeutic approach for cardiogenic shock with multiple organ failure","volume":"20","author":"Seguchi","year":"2017","journal-title":"J Artif Organs"},{"key":"10.1016\/j.ahj.2020.03.006_bb0055","unstructured":"Retrieved from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=cardiogenic+shock. Accessed February 22, 2020."},{"key":"10.1016\/j.ahj.2020.03.006_bb0060","doi-asserted-by":"crossref","unstructured":"Alexander JH, Reynolds HR, Stebbins AL, for the TRIUMPH Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007;297:1657\u201366.","DOI":"10.1001\/jama.297.15.joc70035"},{"key":"10.1016\/j.ahj.2020.03.006_bb0065","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Thelemann N, et al, for the IABP-SHOCK II Trial Investigators. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation 2019;139:395\u2013403.","DOI":"10.1161\/CIRCULATIONAHA.118.038201"},{"key":"10.1016\/j.ahj.2020.03.006_bb0070","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","article-title":"Standardized team-based care for cardiogenic shock","volume":"73","author":"Tehrani","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.03.006_bb0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijcard.2017.06.082","article-title":"Impact of a cardiac intensivist on mortality in patients with cardiogenic shock","volume":"244","author":"Na","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2020.03.006_bb0080","doi-asserted-by":"crossref","unstructured":"Thiele H, Akin I, Sandri M, et al, for the CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017;377:2419\u201332.","DOI":"10.1056\/NEJMoa1710261"},{"key":"10.1016\/j.ahj.2020.03.006_bb0085","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0735-1097(03)01051-9","article-title":"Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial","volume":"42","author":"Sanborn","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.03.006_bb0090","doi-asserted-by":"crossref","unstructured":"Smilowitz NR, Alviar CL, Katz SD, Hochman JS. Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock. Am Heart J 2020;226:264-266.","DOI":"10.1016\/j.ahj.2020.01.020"},{"key":"10.1016\/j.ahj.2020.03.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003846","article-title":"With great power comes great responsibility: \u201cbig data\u201d research from the national inpatient sample","volume":"10","author":"Khera","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2020.03.006_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.athoracsur.2008.03.019","article-title":"Outcomes following surgery and percutaneous intervention for cardiogenic shock and left main disease","volume":"86","author":"Lee","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2020.03.006_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2009.10.035","article-title":"Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease","volume":"159","author":"Mehta","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.03.006_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamacardio.2016.0785","article-title":"Rates of invasive management of cardiogenic shock in New York before and after exclusion from public reporting","volume":"1","author":"Bangalore","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2020.03.006_bb0115","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.athoracsur.2017.06.077","article-title":"Risk aversion and public reporting. Part 1: observations from cardiac surgery and interventional cardiology","volume":"104","author":"Shahian","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2020.03.006_bb0120","unstructured":"Retrieved from: https:\/\/www.medscape.com\/viewarticle\/919890. Accessed February 22, 2020."},{"key":"10.1016\/j.ahj.2020.03.006_bb0125","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","article-title":"The magic of randomization versus the myth of real-world evidence","volume":"382","author":"Collins","year":"2020","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320300818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320300818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:06:14Z","timestamp":1757570774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320300818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"alternative-id":["S0002870320300818"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.03.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Back to the future\u2014Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}